| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
|
Still deciding? Get samples of US$ 160/kg
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
|
Fodostam is a kind of cysteine derivative with steine basic skeleton and expectorant effect. It has multiple pharmacological effects on chronic respiratory diseases: inhibiting the proliferation of respiratory epithelial cells, normalizing the ratio of trehalose-sialic acid in sputum, restoring the status of ciliary transport of airway secretions, and having anti-inflammatory effects; It has the advantages of strong efficacy, small side effects, wide indications, great market potential, etc. It is suitable for expectoration of bronchial asthma, chronic bronchitis, bronchiectasis, tuberculosis, pneumoconiosis, emphysema, atypical mycobacterium infection, diffuse bronchiolitis and other chronic respiratory diseases. |
|
Analysis
|
Specification
|
Result
|
Test method
|
|
Physical Description
|
|
|
|
| Appearance | White powder | White powder |
Visual
|
|
Odor
|
Characteristic
|
Characteristic
|
Organoleptic
|
|
Particle size
|
90% pass 80 mesh
|
90% pass 80 mesh
|
80 Mesh Screen
|
|
Chemical Tests
|
|
|
|
|
Assay (Lutein)
|
99%
|
90.15%
|
HPLC
|
|
Loss on drying
|
5.0% Max
|
1.82%
|
5g/105ºC/2hrs
|
|
Ash Contents
|
5.0% Max
|
1.12%
|
2g/525ºC/3hrs
|
|
Residual Solvents
|
50.0 ppm, Only Ethanol
|
<30.0 ppm
|
/
|
|
Heavy metals
|
5.0 ppm Max
|
<3.0 ppm
|
AAS
|
|
Lead
|
3.0 ppm Max
|
<1.0 ppm
|
AAS
|
|
Arsenic
|
3.0 ppm Max
|
<1.0 ppm
|
AAS
|
|
Microbiology Control
|
|
|
|
|
Total Bacteria Count
|
1,000cfu/g Max
|
<280cfu/g
|
AOAC
|
|
Yeast & Mold
|
100cfu/g Max
|
<10cfu/g
|
AOAC
|
|
Coliform
|
30.0 MPN/g Max
|
<3.0 MPN/g
|
AOAC
|
|
Conclusion
|
Complies with the standards.
|
||
|
General Status
|
Non-GMO, ISO Certificated.
|
||
){kind=link}